Food‐induced changes in theophylline absorption from controlled‐release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo‐Dur Sprinkle

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Clinical pharmacology and therapy

• Publication date

  1985-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/clpt.1985.138PMID 4006379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet

  2004cited by this paper
• Food-induced dose dumping of Theo-24.

  1985cited by this paper
• A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products

  1984cited by this paper
• Effect of using an incorrect elimination rate constant in application of the Wagner-Nelson method to theophylline data in cases of zero order absorption.

  1984cited by this paper
• Erratic absorption of a slow-release theophylline sprinkle product.

  1984cited by this paper
• Influence of Pharmacokinetic Diurnal Variation on Bioavailability Estimates

  1984cited by this paper
• Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.

  1984cited by this paper
• Dose Dependency for Absorption and Elimination Rates of Theophylline Implications for Studies of Bioavailability

  1984cited by this paper
• Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.

  1983cited by this paper
• Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.

  1983cited by this paper
• Evaluation of the effect of nonlinear kinetics on dosage adjustments of theophylline.

  1983cited by this paper
• Nonlinear theophylline elimination

  1982cited by this paper
• Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults

  1982cited by this paper
• A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies

  1982cited by this paper
• Effect of Food on the Bioavailability and Pattern of Release of a Sustained‐Release Theophylline Tablet

  1982cited by this paper
• Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food.

  1981cited by this paper
• Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.

  1980cited by this paper
• Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria

  1980cited by this paper
• The relation of product formulation to absorption of oral theophylline.

  1978cited by this paper
• Enhanced biotransformation of theophylline in marihuana and tobacco smokers

  1978cited by this paper
• Dose-dependent kinetics of theophylline disposition in asthmatic children.

  1977cited by this paper
• Relationship of theophylline clearance to oral dosage in children with chronic asthma.

  1977cited by this paper
• Per cent absorbed time plots derived from blood level and/or urinary excretion data.

  1963cited by this paper

• Current status and usefulness of therapeutic drug monitoring implementation of theophylline in elderly patients based on a nationwide database study and modeling approach

  2024cites this paper
• Food–drug interactions and their implications on oral drug bioavailability

  2022cites this paper
• Food Interactions Observed in a Pharmacokinetic Investigation Comparing Two Marketed Cold Preparations (BNO1016 and ELOM-080) after Administration to Beagle Dogs – A Pilot Study

  2021cites this paper
• Food interactions observed in a pharmacokinetic investigation comparing two marketed cold preparations (BNO1016 and ELOM-080) after administration to male beagle dogs

  2021cites this paper
• The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.

  2019cites this paper
• A new validated HPLC method for the determination of levodopa: Application to study the impact of ketogenic diet on the pharmacokinetics of levodopa in Parkinson's participants.

  2018cites this paper
• Robustness of barrier membrane coated metoprolol tartrate matrix tablets: Drug release evaluation under physiologically relevant in vitro conditions

  2018cites this paper
• The dynamic gastric environment and its impact on drug and formulation behaviour.

  2017cites this paper
• A review of in vivo and in vitro aspects of alcohol-induced dose dumping

  2017cites this paper
• Dissolution Test Considerations for Oral Multiparticulate Systems

  2017cites this paper
• Drug release from matrix tablets: physiological parameters and the effect of food

  2014cites this paper
• Evolving Biopharmaceutics Perspectives for Hydrophilic Matrix Tablets: Dosage Form–Food Interactions and Dosage Form Gastrointestinal Tract Interactions

  2014cites this paper
• The Effects of Food on Drug Bioavailability and Bioequivalence

  2014cites this paper
• Hydrophilic Matrix Tablets for Oral Controlled Release

  2014cites this paper
• Food-Drug Interactions

  2012cites this paper
• Effects of Food on Drug Absorption

  2011cites this paper
• Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.

  2010cites this paper
• Substitution of Theophylline Slow-Release Formulations According to the Rebate Contracts in the German Statutory Health Insurance

  2009cites this paper
• DEVELOPMENT OF AN IN VITRO METHOD TO HELP PREDICT IN VIVO BEHAVIOR OF CONTROLLED RELEASE PRODUCTS

  2009influential citation
• Predicting Food Effects on Drug Release from Extended-Release Oral Dosage Forms Containing a Narrow Therapeutic Index Drug

  2009cites this paper
• Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.

  2008cites this paper
• Food Effects on Drug Bioavailability: Implications for New and Generic Drug Development

  2008cites this paper
• Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.

  2006cites this paper
• Arzneizubereitungen mit Calciumkanal‐Blockern: Wie die Arzneiform zum Therapieerfolg beiträgt

  2005cites this paper
• Food-Effect Bioavailability and Fed Bioequivalence Studies

  2005cites this paper
• Theophylline and Phosphodiesterase Inhibitors

  2005cites this paper
• [Drug preparations of calcium channel blockers].

  2005cites this paper
• Food-Drug Interactions: Drug Development Considerations

  2004cites this paper
• Design of a new multiple-unit controlled-release formulation of metoprolol — Metoprolol CR

  2004cites this paper
• The Effect of Food on the Absorption of Controlled-Release Theophylline in Mini-Swine

  2004cites this paper
• The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.

  2002cites this paper
• Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.

  2002cites this paper
• Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast

  2002cites this paper
• Application of fibroin in controlled release tablets containing theophylline.

  2000cites this paper
• [The effect of food on theophylline absorption].

  1998cites this paper
• [Requirements for product quality of theophylline sustained-release preparations].

  1998cites this paper
• Clinical Pharmacokinetics of Nisoldipine Coat-Core

  1998cites this paper
• Influence of food on the bioavailability of a carbamazepine slow-release formulation.

  1997cites this paper
• PHARMACOKINETICS OF ONCE-DAILY VENLAFAXINE EXTENDED RELEASE IN HEALTHY VOLUNTEERS

  1997cites this paper
• Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.

  1997cites this paper
• Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form

  1997cites this paper
• EXAMINATION OF ABSORPTION RATES OF SUSTAINTED RELEASE THEOPHYLLINE PREPARATION AND AMINOPHYLLINE ON THE DETERMINATION OF THEOPHYLLINE IN FACES

  1997cites this paper
• In Vivo Bioavailability of a Multiparticulate Matrix Sustained-Release Theophylline Preparation Under Fed and Fasted Conditions

  1997cites this paper
• Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: Challenges and opportunities

  1996cites this paper
• Influence of Endogenous and Exogenous Effectors on the Pharmacokinetics of Theophylline

  1995cites this paper
• Theophylline in the management of asthma: time for a reappraisal?

  1995cites this paper
• Conversion from twice- to once-daily extended-release theophylline treatment in patients with reversible airway obstruction.

  1995cites this paper
• Asthma

  1995cites this paper
• Study on the influence of food on the absorption of theophylline from a controlled-release preparation.

  1994cites this paper
• Theophylline toxicity.

  1993cites this paper
• [The effect of food on the pharmacokinetics of drugs].

  1993cites this paper
• Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled release formulation

  1993cites this paper
• International Harmonization of Regulatory Bioequivalence Requirements

  1993cites this paper
• Absence of food effects on the pharmacokinetics of terfenadine

  1992cites this paper
• Presentation of results from bioequivalence studies.

  1992cites this paper
• Presentation of results from bioequivalence studies.

  1992cites this paper
• Controversies in Bioequivalence Studies

  1992cites this paper
• Plasma theophylline concentrations and airway function in asthmatic children receiving standard and modified RTC therapy.

  1992cites this paper
• Striving for standards in bioequivalence assessment: a review.

  1992cites this paper
• Lack of Effect of a High‐Fat Meal on the Volume of Distribution of Theophylline in Humans

  1991cites this paper
• Striving for standards in bioequivalence assessment: a review.

  1991cites this paper
• Repeated dosing of Uniphyl tablets under fed and fasting conditions: comparison of serum theophylline levels, pulmonary function, and asthma symptoms.

  1991cites this paper
• Effect of fatty diet on pharmacokinetics and pharmacodynamics of a liquid theophylline preparation in volunteers.

  1991cites this paper
• Pharmacists' substitution of slow release theophylline products. Committee on Drugs, American College of Allergy and Immunology.

  1991cites this paper
• Effect of a Light Breakfast on the Bioavailability of Sustained-Release Nifedipine

  1991cites this paper
• Sustained-release theophylline preparations.

  1990cites this paper
• Theophylline

  1990cites this paper
• The Effect of Food on Gastrointestinal (GI) Transit of Sustained-Release Ibuprofen Tablets as Evaluated by Gamma Scintigraphy

  1990cites this paper
• Absence of effect of food on alprazolam absorption from sustained release tablets.

  1990cites this paper
• Theophylline-Controlled Release Preparations and Fatty Food: An in Vitro Study Using the Rotating Dialysis Cell Method

  1990cites this paper
• Effect of Food on Nifedipine Sustained-Release Preparation

  1989cites this paper
• Asthma in childhood.

  1989cites this paper
• The Beagle Dog as an Animal Model for a Bioavailability Study of Controlled-Release Theophylline Under the Influence of Food

  1989cites this paper
• The clinical significance of food‐drug interactions: a review

  1989cites this paper
• Influence of hyperlipidic food on the kinetics of slow-release formulations of theophylline

  1989cites this paper
• Effects of food on drug absorption.

  1989cites this paper
• Pseudoephedrine absorption from controlled release formulations: Absorption rate constant estimation methods

  1989cites this paper
• Gastrointestinal Transit of a Solid Indigestible Capsule as Measured by Radiotelemetry and Dual Gamma Scintigraphy

  1989cites this paper
• Effects of time of dose in relation to food on the bioavailability of Theo‐Dur Sprinkle at steady state in asthmatic children

  1989cites this paper
• Food Interactions with Sustained-Release Theophylline Preparations

  1989cites this paper
• Slow release theophylline disposition and effect in elderly patients with chronic obstructive lung disease: influence of dose formulation and institutionalization.

  1989cites this paper
• Antiasthmatic therapy in children.

  1989cites this paper
• Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals.

  1989cites this paper
• [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].

  1989cites this paper
• Pharmacist substitution of slow-release theophylline products.

  1989cites this paper
• INFLUENCE OF FOOD ON BIOAVAILABILITY FROM TWO CONTROLLED‐RELEASE GRANULES OF THEOPHYLLINE

  1989cites this paper
• Effect of dietary cellulose on the absorption and bioavailability of theophylline

  1989cites this paper
• An in vitro model for exploring CR theophylline-milk fat interactions

  1989cites this paper
• Effects of capsicum fruit on theophylline absorption and bioavailability in rabbits.

  1988cites this paper
• [Theophylline-retard preparations: relation between drug liberation in vitro and their behavior in the human body].

  1988cites this paper
• Influence of food on steady state serum concentrations of theophylline from two controlled-release preparations.

  1988cites this paper
• Circadian variation in theophylline absorption during chronic dosing with a slow release theophylline preparation and the effect of clock time of dosing.

  1988cites this paper
• Food-Induced Theophylline Release/Absorption Changes from Controlled-Release Formulations: A Proposed In Vitro Model

  1988cites this paper
• Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.

  1988cites this paper
• Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma.

  1988cites this paper
• Methylxanthines: toxicity to humans. 1. Theophylline.

  1988cites this paper
• Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines.

  1988cites this paper
• The clinical significance of food-induced changes in the absorption of theophylline from Uniphyl tablets.

  1988cites this paper
• Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.

  1988cites this paper
• Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension

  1988cites this paper